Point-of-care (POC) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made.
Highlights
The global PoC Platform and Technology market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for PoC Platform and Technology is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for PoC Platform and Technology is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for PoC Platform and Technology in Hospitals is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of PoC Platform and Technology include Roche, Abbott, LifeScan, Inc, Siemens Healthcare, Danaher, Ascensia, Bio-Rad Laboratories, BioMerieux and ARKRAY, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for PoC Platform and Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PoC Platform and Technology.
The PoC Platform and Technology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global PoC Platform and Technology market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the PoC Platform and Technology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Roche
Abbott
LifeScan, Inc
Siemens Healthcare
Danaher
Ascensia
Bio-Rad Laboratories
BioMerieux
ARKRAY
Nova Biomedical
Trividia Health
Quidel
Accriva (Werfen)
OraSure Technologies
Helena Laboratories
A. Menarini Diagnostics
Abaxis (Zoetis)
Ortho Clinical Diagnostics
Phamatech
Chembio Diagnostics
Trinity Biotech
ELITech Group
Response Biomedical
Princeton BioMeditech
Alfa Wassermann
Segment by Type
Blood Glucose Testing
Infectious Diseases Testing
Cardiac Markers Testing
Coagulation Testing
Pregnancy and Fertility Testing
Blood Gas/Electrolytes Testing
Urinalysis Testing
Others
Segment by Application
Hospitals
Clinics
Laboratory
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of PoC Platform and Technology companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global PoC Platform and Technology 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Blood Glucose Testing
1.2.3 Infectious Diseases Testing
1.2.4 Cardiac Markers Testing
1.2.5 Coagulation Testing
1.2.6 Pregnancy and Fertility Testing
1.2.7 Blood Gas/Electrolytes Testing
1.2.8 Urinalysis Testing
1.2.9 Others
1.3 麻豆原创 by Application
1.3.1 Global PoC Platform and Technology 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Laboratory
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global PoC Platform and Technology 麻豆原创 Perspective (2018-2029)
2.2 PoC Platform and Technology Growth Trends by Region
2.2.1 Global PoC Platform and Technology 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 PoC Platform and Technology Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 PoC Platform and Technology Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 PoC Platform and Technology 麻豆原创 Dynamics
2.3.1 PoC Platform and Technology Industry Trends
2.3.2 PoC Platform and Technology 麻豆原创 Drivers
2.3.3 PoC Platform and Technology 麻豆原创 Challenges
2.3.4 PoC Platform and Technology 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top PoC Platform and Technology Players by Revenue
3.1.1 Global Top PoC Platform and Technology Players by Revenue (2018-2023)
3.1.2 Global PoC Platform and Technology Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global PoC Platform and Technology 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by PoC Platform and Technology Revenue
3.4 Global PoC Platform and Technology 麻豆原创 Concentration Ratio
3.4.1 Global PoC Platform and Technology 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by PoC Platform and Technology Revenue in 2022
3.5 PoC Platform and Technology Key Players Head office and Area Served
3.6 Key Players PoC Platform and Technology Product Solution and Service
3.7 Date of Enter into PoC Platform and Technology 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 PoC Platform and Technology Breakdown Data by Type
4.1 Global PoC Platform and Technology Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global PoC Platform and Technology Forecasted 麻豆原创 Size by Type (2024-2029)
5 PoC Platform and Technology Breakdown Data by Application
5.1 Global PoC Platform and Technology Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global PoC Platform and Technology Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America PoC Platform and Technology 麻豆原创 Size (2018-2029)
6.2 North America PoC Platform and Technology 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America PoC Platform and Technology 麻豆原创 Size by Country (2018-2023)
6.4 North America PoC Platform and Technology 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe PoC Platform and Technology 麻豆原创 Size (2018-2029)
7.2 Europe PoC Platform and Technology 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe PoC Platform and Technology 麻豆原创 Size by Country (2018-2023)
7.4 Europe PoC Platform and Technology 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific PoC Platform and Technology 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific PoC Platform and Technology 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific PoC Platform and Technology 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific PoC Platform and Technology 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America PoC Platform and Technology 麻豆原创 Size (2018-2029)
9.2 Latin America PoC Platform and Technology 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America PoC Platform and Technology 麻豆原创 Size by Country (2018-2023)
9.4 Latin America PoC Platform and Technology 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa PoC Platform and Technology 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa PoC Platform and Technology 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa PoC Platform and Technology 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa PoC Platform and Technology 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche PoC Platform and Technology Introduction
11.1.4 Roche Revenue in PoC Platform and Technology Business (2018-2023)
11.1.5 Roche Recent Development
11.2 Abbott
11.2.1 Abbott Company Detail
11.2.2 Abbott Business Overview
11.2.3 Abbott PoC Platform and Technology Introduction
11.2.4 Abbott Revenue in PoC Platform and Technology Business (2018-2023)
11.2.5 Abbott Recent Development
11.3 LifeScan, Inc
11.3.1 LifeScan, Inc Company Detail
11.3.2 LifeScan, Inc Business Overview
11.3.3 LifeScan, Inc PoC Platform and Technology Introduction
11.3.4 LifeScan, Inc Revenue in PoC Platform and Technology Business (2018-2023)
11.3.5 LifeScan, Inc Recent Development
11.4 Siemens Healthcare
11.4.1 Siemens Healthcare Company Detail
11.4.2 Siemens Healthcare Business Overview
11.4.3 Siemens Healthcare PoC Platform and Technology Introduction
11.4.4 Siemens Healthcare Revenue in PoC Platform and Technology Business (2018-2023)
11.4.5 Siemens Healthcare Recent Development
11.5 Danaher
11.5.1 Danaher Company Detail
11.5.2 Danaher Business Overview
11.5.3 Danaher PoC Platform and Technology Introduction
11.5.4 Danaher Revenue in PoC Platform and Technology Business (2018-2023)
11.5.5 Danaher Recent Development
11.6 Ascensia
11.6.1 Ascensia Company Detail
11.6.2 Ascensia Business Overview
11.6.3 Ascensia PoC Platform and Technology Introduction
11.6.4 Ascensia Revenue in PoC Platform and Technology Business (2018-2023)
11.6.5 Ascensia Recent Development
11.7 Bio-Rad Laboratories
11.7.1 Bio-Rad Laboratories Company Detail
11.7.2 Bio-Rad Laboratories Business Overview
11.7.3 Bio-Rad Laboratories PoC Platform and Technology Introduction
11.7.4 Bio-Rad Laboratories Revenue in PoC Platform and Technology Business (2018-2023)
11.7.5 Bio-Rad Laboratories Recent Development
11.8 BioMerieux
11.8.1 BioMerieux Company Detail
11.8.2 BioMerieux Business Overview
11.8.3 BioMerieux PoC Platform and Technology Introduction
11.8.4 BioMerieux Revenue in PoC Platform and Technology Business (2018-2023)
11.8.5 BioMerieux Recent Development
11.9 ARKRAY
11.9.1 ARKRAY Company Detail
11.9.2 ARKRAY Business Overview
11.9.3 ARKRAY PoC Platform and Technology Introduction
11.9.4 ARKRAY Revenue in PoC Platform and Technology Business (2018-2023)
11.9.5 ARKRAY Recent Development
11.10 Nova Biomedical
11.10.1 Nova Biomedical Company Detail
11.10.2 Nova Biomedical Business Overview
11.10.3 Nova Biomedical PoC Platform and Technology Introduction
11.10.4 Nova Biomedical Revenue in PoC Platform and Technology Business (2018-2023)
11.10.5 Nova Biomedical Recent Development
11.11 Trividia Health
11.11.1 Trividia Health Company Detail
11.11.2 Trividia Health Business Overview
11.11.3 Trividia Health PoC Platform and Technology Introduction
11.11.4 Trividia Health Revenue in PoC Platform and Technology Business (2018-2023)
11.11.5 Trividia Health Recent Development
11.12 Quidel
11.12.1 Quidel Company Detail
11.12.2 Quidel Business Overview
11.12.3 Quidel PoC Platform and Technology Introduction
11.12.4 Quidel Revenue in PoC Platform and Technology Business (2018-2023)
11.12.5 Quidel Recent Development
11.13 Accriva (Werfen)
11.13.1 Accriva (Werfen) Company Detail
11.13.2 Accriva (Werfen) Business Overview
11.13.3 Accriva (Werfen) PoC Platform and Technology Introduction
11.13.4 Accriva (Werfen) Revenue in PoC Platform and Technology Business (2018-2023)
11.13.5 Accriva (Werfen) Recent Development
11.14 OraSure Technologies
11.14.1 OraSure Technologies Company Detail
11.14.2 OraSure Technologies Business Overview
11.14.3 OraSure Technologies PoC Platform and Technology Introduction
11.14.4 OraSure Technologies Revenue in PoC Platform and Technology Business (2018-2023)
11.14.5 OraSure Technologies Recent Development
11.15 Helena Laboratories
11.15.1 Helena Laboratories Company Detail
11.15.2 Helena Laboratories Business Overview
11.15.3 Helena Laboratories PoC Platform and Technology Introduction
11.15.4 Helena Laboratories Revenue in PoC Platform and Technology Business (2018-2023)
11.15.5 Helena Laboratories Recent Development
11.16 A. Menarini Diagnostics
11.16.1 A. Menarini Diagnostics Company Detail
11.16.2 A. Menarini Diagnostics Business Overview
11.16.3 A. Menarini Diagnostics PoC Platform and Technology Introduction
11.16.4 A. Menarini Diagnostics Revenue in PoC Platform and Technology Business (2018-2023)
11.16.5 A. Menarini Diagnostics Recent Development
11.17 Abaxis (Zoetis)
11.17.1 Abaxis (Zoetis) Company Detail
11.17.2 Abaxis (Zoetis) Business Overview
11.17.3 Abaxis (Zoetis) PoC Platform and Technology Introduction
11.17.4 Abaxis (Zoetis) Revenue in PoC Platform and Technology Business (2018-2023)
11.17.5 Abaxis (Zoetis) Recent Development
11.18 Ortho Clinical Diagnostics
11.18.1 Ortho Clinical Diagnostics Company Detail
11.18.2 Ortho Clinical Diagnostics Business Overview
11.18.3 Ortho Clinical Diagnostics PoC Platform and Technology Introduction
11.18.4 Ortho Clinical Diagnostics Revenue in PoC Platform and Technology Business (2018-2023)
11.18.5 Ortho Clinical Diagnostics Recent Development
11.19 Phamatech
11.19.1 Phamatech Company Detail
11.19.2 Phamatech Business Overview
11.19.3 Phamatech PoC Platform and Technology Introduction
11.19.4 Phamatech Revenue in PoC Platform and Technology Business (2018-2023)
11.19.5 Phamatech Recent Development
11.20 Chembio Diagnostics
11.20.1 Chembio Diagnostics Company Detail
11.20.2 Chembio Diagnostics Business Overview
11.20.3 Chembio Diagnostics PoC Platform and Technology Introduction
11.20.4 Chembio Diagnostics Revenue in PoC Platform and Technology Business (2018-2023)
11.20.5 Chembio Diagnostics Recent Development
11.21 Trinity Biotech
11.21.1 Trinity Biotech Company Detail
11.21.2 Trinity Biotech Business Overview
11.21.3 Trinity Biotech PoC Platform and Technology Introduction
11.21.4 Trinity Biotech Revenue in PoC Platform and Technology Business (2018-2023)
11.21.5 Trinity Biotech Recent Development
11.22 ELITech Group
11.22.1 ELITech Group Company Detail
11.22.2 ELITech Group Business Overview
11.22.3 ELITech Group PoC Platform and Technology Introduction
11.22.4 ELITech Group Revenue in PoC Platform and Technology Business (2018-2023)
11.22.5 ELITech Group Recent Development
11.23 Response Biomedical
11.23.1 Response Biomedical Company Detail
11.23.2 Response Biomedical Business Overview
11.23.3 Response Biomedical PoC Platform and Technology Introduction
11.23.4 Response Biomedical Revenue in PoC Platform and Technology Business (2018-2023)
11.23.5 Response Biomedical Recent Development
11.24 Princeton BioMeditech
11.24.1 Princeton BioMeditech Company Detail
11.24.2 Princeton BioMeditech Business Overview
11.24.3 Princeton BioMeditech PoC Platform and Technology Introduction
11.24.4 Princeton BioMeditech Revenue in PoC Platform and Technology Business (2018-2023)
11.24.5 Princeton BioMeditech Recent Development
11.25 Alfa Wassermann
11.25.1 Alfa Wassermann Company Detail
11.25.2 Alfa Wassermann Business Overview
11.25.3 Alfa Wassermann PoC Platform and Technology Introduction
11.25.4 Alfa Wassermann Revenue in PoC Platform and Technology Business (2018-2023)
11.25.5 Alfa Wassermann Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Roche
Abbott
LifeScan, Inc
Siemens Healthcare
Danaher
Ascensia
Bio-Rad Laboratories
BioMerieux
ARKRAY
Nova Biomedical
Trividia Health
Quidel
Accriva (Werfen)
OraSure Technologies
Helena Laboratories
A. Menarini Diagnostics
Abaxis (Zoetis)
Ortho Clinical Diagnostics
Phamatech
Chembio Diagnostics
Trinity Biotech
ELITech Group
Response Biomedical
Princeton BioMeditech
Alfa Wassermann
听
听
*If Applicable.
